Quick Search

 

 


 

 

Home > Result Summaries: Compounds > fluticasone propionate/salmeterol > Result Summary for ADA109055

Result Summary for ADA109055

Result Summary
Protocol ID: ADA109055
Clinical Study ID: ADA109055
Official Title: A 52-week, Randomized, Double-Blind, Parallel-Group Study of Fluticasone Propionate/Salmeterol DISKUS Combination Product (FSC) 250/50 mcg BID and Fluticasone Propionate (FP) DISKUS 250 mcg BID in Treatment of Subjects with Asthma
Phase: phase 4
Study Indications or Diseases:
  • Asthma
Generic Name: fluticasone propionate/salmeterol
Trade/Product Name: Viani,Seretide Diskus,Seretide Accuhaler,Seretide,Advair DISKUS
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:
  • Katial RK, Bernstein D, et. al.. Long-term treatment with fluticasone propionate/salmeterol via Diskus impoves asthma control verus fluticasone propionate alone. Allergy Asthma Proc. 2011;32:1 - 10.

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.